Local hyperthermia abrogates the anti-immunotherapeutic effect of interleukin-8

Structure and expression of a cloned cDNA for human interleukin-2

1983 • 1,176 citations

Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

1989 • 1,003 citations

Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coli

1984 • 600 citations

Endothelial Interleukin-8: A Novel Inhibitor of Leukocyte-Endothelial Interactions

1989 • 459 citations

In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2.

1988 • 82 citations

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.

1986 • 75 citations

Preferential Localization of Human Adherent Lymphokine-Activated Killer Cells in Tumor Microcirculation

1991 • 71 citations

Interleukin 2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome.

1991 • 62 citations

Antitumor effect of recombinant tumor necrosis factor-? against murine sarcomas at visceral sites: tumor size influences the response to therapy

1988 • 42 citations

Effects of sequencing of the total course of combined hyperthermia and radiation on the RIF-1 murine tumor

1984 • 13 citations

The specificity of lymphokine-activated killer (LAK) cells in vitro: fresh normal murine tissues are resistant to LAK-mediated lysis

1991 • 11 citations

Immunotherapy and whole‐body hyperthermia as combined modality treatment of a subcutaneous murine sarcoma

1993 • 9 citations